From: Lamont Granquist Newsgroups: sci.med.psychobiology,sci.med.pharmacy,alt.psychoactives,alt.drugs Subject: SSRI Neurochemistry Date: 10 Sep 1994 23:13:54 GMT Message-ID: <34teji$f6t@news.u.washington.edu> As mentioned in the original article, these drugs typically have active metabolites which may be significant. Thus, actual in vivo activity may be slightly different. Receptor Affinities for SSRI drugs (Values normalized to the IC50 for 5-HT reuptake) [Data Taken from: Internatn-Clin-Psychopharm, 9 suppl 1: 19-26 (1994)] Clomiprimine Fluoxetine Sertraline Paroxetine Fluvoxamine (Prozac) (Zoloft) (Paxil) 5HTRI: 1 5HTRI: 1 5HTRI: 1 5HTRI: 1 5HTRI: 1 NARI: 14 NARI: 54 DARI: 250 NARI: 280 NARI: 160 H1: 36 5HT2A: 100 NARI: 840 ACh: 720 Alpha2: 500 5HT2A 36 5HT2C: 235 ACh: 5,800 DARI: 18,000 Alpha1: 1,300 Alpha1: 40 Beta: 264 Alpha2: 9,500 D1: 52,000 5HT2C: 1,800 ACh: 45 Alpha2: 410 Alpha1: 15,000 5HT2A: 62,000 H1: 2,900 D1: 130 ACh: 445 D1: 33,000 H1: 66,000 5HT2A: 3,200 D2: 290 H1: 470 5HT2A: 45,000 Alpha1: 66,000 ACh: 8,900 Alpha2: 1,200 DARI: 740 H1: 53,000 5HT2C: 69,000 DARI: 11,000 5HT1A: 1,900 D1: 1,500 Beta: 74,000 Beta: 120,000 D2: 17,000 DARI: 2,900 Alpha1: 2,000 D2: 130,000 D2: 180,000 Beta: 23,000 Beta: 15,000 D2: 4,700 5HT1A: >530,000 Alpha2: 300,000 D1: >26,000 5HT2C: NA 5HT1A: 12,000 5HT2C: NA 5HT1A: >340,000 5HT1A: >26,000 Citalopram 5HTRI: 1 H1: 220 5HT2C: 350 Alpha1: 890 Alpha2: 1,000 ACh: 3,100 5HT2A: 3,100 NARI: 3,400 5HT1A: 8,300 D1: 12,000 D2: 18,000 DARI: 22,000 Beta: >56,000 Radioligands used in binding: D1: SCH23390; D2: Spiperone; 5-HT1A: 5-OH-DPAT; 5-HT2A: Ketanserin; 5-HT2C: Ly278584; Alpha1: Prazosin; Alpha2: Idazoxan; Beta: Dihydroalprenolol; H1: Mepyramine; ACh: QNB. -- Lamont Granquist "In a saner world his [Noam Chomsky's] tireless efforts to promote justice would have long since won him the Nobel Peace Prize, but the committee keeps giving it to people like Henry Kissinger." -- Arthur Naiman
Modern humans must learn how to relate to psychoactives
responsibly, treating them with respect and awareness,
working to minimize harms and maximize benefits, and
integrating use into a healthy, enjoyable, and productive life.
responsibly, treating them with respect and awareness,
working to minimize harms and maximize benefits, and
integrating use into a healthy, enjoyable, and productive life.